dailypolitical.com
Positivewww.dailypolitical.com ·
Omnicell Inc Nasdaqomcl Receives 59 86 Consensus Target Price From Analysts
Econ PriceExecutiveMedicalNatural Resource Management
Topic context
This topic has been covered 403889 times in the last 30 days across our monitored publishers.
The full article is on the original publisher site. This page only shows the headline and a very short excerpt.
AI insight
AI-generatedThe article covers analyst consensus and earnings for Omnicell, a healthcare technology company. No direct commercial mechanism (price change, supply disruption, regulation, or investment) is reported. The impact is limited to equity sentiment for OMCL; no sector-wide or supply-chain effect is evident.
Signals our AI researcher identified
Extracted by our AI model from this article and related public sources — not direct quotes from the publisher.
- Omnicell (OMCL) consensus target price $59.86 from 9 analysts, average rating 'Buy'.
- Q2 2026 EPS $0.55 vs estimates, revenue $309.88M (+14.9% YoY).
- Insider sales: EVP Nnamdi Njoku sold 3,090 shares, EVP Corey J. Manley sold 5,025 shares on May 18, 2026.
- Institutional ownership 97.70%; several hedge funds increased stakes recently.
Related stories
finance.yahoo.com
Ncmi Q1 2026 Earnings Transcript
finance.yahoo.com
Transcript Valneva Q1 2026 Earnings
finance.yahoo.com
Aytu Aytu Q3 2026 Earnings
fool.com
Keysight Keys Q2 2026 Earnings Transcript
livemint.com